PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-65.20%
Both yoy net incomes decline, with BTE at -208.81%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-5.11%
Negative yoy D&A while BTE is 404.92%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
285.96%
Well above BTE's 95.82% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
74.00%
Well above BTE's 33.89% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
74.00%
Growth well above BTE's 33.89%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-92.71%
Both negative yoy, with BTE at -126.62%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-15.63%
Both yoy CFO lines are negative, with BTE at -25.10%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-16.17%
Negative yoy CapEx while BTE is 26.90%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.74%
We reduce yoy other investing while BTE is 36.19%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-510.35%
We reduce yoy invests while BTE stands at 28.89%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-90.48%
Negative yoy issuance while BTE is 2599.84%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.